Braganza

Braganza is a Swedish-Norwegian privately held investment company and family office owned by the Per G. Braathen family. While the group's core business is centered on the travel, aviation, and tourism industries, it maintains a strategic focus on the life sciences and healthcare sectors through direct investments and private equity. Braganza has historically backed innovative biotech firms such as Affitech and Clavis Pharma, focusing on therapeutic areas like oncology and immunology. The firm operates as an active owner, leveraging its financial expertise to support the growth of its portfolio companies across Northern Europe and beyond.